| Previous Close | 0.0700 |
| Open | 0.0000 |
| Bid | 0.0750 x 0 |
| Ask | 0.0800 x 0 |
| Day's Range | 0.0000 - 0.0000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 2,382,335 |
| Market Cap | 14.718M |
| Beta (5Y Monthly) | 2.63 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0260 |
| Earnings Date | Aug. 14, 2019 - Aug. 15, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Empower Clinics Signs North American Distribution Agreement with API Pharma USA For FDA EUA COVID-Rapid Antigen & Antibody Tests. Supported Three Months of Clinical Trials
EMPOWER'S KAI Medical Laboratory Also Supporting API Pharma With Health Canada Submission of COVID Rapid Antigen Test and Signs National Distribution AgreementVANCOUVER, BC / ACCESSWIRE / November 30, 2020 / EMPOWER CLINICS INC.
- ACCESSWIRE
Empower Reports Q3 2020 Results With 67% Revenue Increase for The Nine Months Ended September 30, 2020
VANCOUVER, BC / ACCESSWIRE / November 25, 2020 / EMPOWER CLINICS INC.
- ACCESSWIRE
Empower Clinics Kai Medical Lab to Introduce New Influenza A/B COVID RT-PCR Test to Differentiate Influenza From COVID-19. Recent $1,000,000 Testing Order to Utilize New Protocol the Kai ABC RT-PCR Test
Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, TX was acquired by Empower Clinics on October 6, 2020 to further advance the Company's COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and collegesVANCOUVER BC / ACCESSWIRE / November 19, 2020 / EMPOWER CLINICS INC.
© 2020 Verizon Media. All rights reserved.
